The Food and Drug Administration is facing backlash over its approval of a genetic test intended to determine if a person is at increased risk for opioid addiction.
Related Posts
Seattle hospital won’t turn over gender-affirming care records in lawsuit settlement with Texas
- blkalertshealth
- April 24, 2024
- 0
Texas Attorney General Ken Paxton is dropping a re
AT&T investigating leak that dumped millions of customers’ data on dark web
- blkalertshealth
- March 31, 2024
- 0
AT&T is investigating a leak earlier this month th
Suspected counterfeit botox now linked to adverse reactions in 11 states
- blkalertshealth
- April 21, 2024
- 0
New York City reported three cases of botulism-lik